Inhibrx Biosciences Inc [INBX] stock prices are up 1.90% to $13.39 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INBX shares have gain 6.27% over the last week, with a monthly amount drifted -0.59%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Inhibrx Biosciences Inc [INBX] has been fluctuating between $10.80 and $18.95 over the past year. Inhibrx Biosciences Inc [NASDAQ: INBX] shares were valued at $13.39 at the most recent close of the market.
Analyzing the INBX fundamentals
Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at -213.27%, Pretax Profit Margin comes in at 947.79%, and Net Profit Margin reading is 946.85%. To continue investigating profitability, this company’s Return on Assets is posted at 7.38, Equity is 14.5 and Total Capital is -2.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.09 points at the first support level, and at 12.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.64, and for the 2nd resistance point, it is at 13.90.
Ratios To Look Out For
It’s worth pointing out that Inhibrx Biosciences Inc [NASDAQ:INBX]’s Current Ratio is 4.70. Also, the Quick Ratio is 4.70, while the Cash Ratio stands at 4.45.
Transactions by insiders
Recent insider trading involved Kayyem Jon Faiz, Director, that happened on Nov 19 ’24 when 69686.0 shares were purchased. Director, Kayyem Jon Faiz completed a deal on Nov 20 ’24 to buy 37500.0 shares. Meanwhile, Chief Executive Officer Lappe Mark bought 26963.0 shares on Sep 12 ’24.
